Nucleotide Delivery
The field of RNA interference represents a potential revolution in medicine and a new approach to treating disease. Â Aonys provides a highly protective environment for both native and modified oligonucleotides and allows buccal administration and absorption.
More »
Neurology
Neurodegeneration refers to the progressive loss of neuron function leading to a variety of pathologies involving both motor function and dementia.
More »
Diabetes
Diabetes mellitus is a chronic disease accounting for 90% of all diagnosed diabetes cases and is mainly characterised by elevated blood glucose levels resulting from defects in insulin secretion and insulin action.
More »Latest news from Medesis Pharma
Medesis Pharma, the French based pharmaceutical company, announces the successful completion of a phase I clinical trial of NP01, a first in class anti-diabetic for the treatment of type 2 diabetes mellitus.
More »Medesis Pharma will give a keynote presentation at the SMi 5th Conference on RNAi, siRNA and miRNA.
More »Medesis Pharma's treatment for Huntington's disease has received a positive opinion for orphan drug designation from the Committee for Ophan Medicinal Products (COMP)
More »You might want to look at
- Medesis Pharma Successfully Completes Phase I Clinical Trial of NP01
- Letter to patients suffering from Huntington’s disease
Upcoming events at Medesis:
